KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)R&D In ProcessReceivables - NetShares OutstandingShares OutstandingShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Pfizer (PFE) Short-Term Debt issuances (2016 - 2026)

Pfizer has reported Short-Term Debt issuances over the past 18 years, most recently at -$127.0 million for Q1 2026.

  • Quarterly Short-Term Debt issuances rose 67.1% to -$127.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $259.0 million through Mar 2026, up 106.35% year-over-year, with the annual reading at $8.9 billion for FY2024, 181.78% up from the prior year.
  • Short-Term Debt issuances was -$127.0 million for Q1 2026 at Pfizer, down from $903.0 million in the prior quarter.
  • Over five years, Short-Term Debt issuances peaked at $4.2 billion in Q3 2022 and troughed at -$2.6 billion in Q3 2024.
  • The 5-year median for Short-Term Debt issuances is -$127.0 million (2026), against an average of $557.1 million.
  • Year-over-year, Short-Term Debt issuances soared 16828.0% in 2022 and then crashed 1100.47% in 2024.
  • A 5-year view of Short-Term Debt issuances shows it stood at $3.9 billion in 2022, then fell by 19.04% to $3.1 billion in 2023, then plummeted by 182.3% to -$2.6 billion in 2024, then surged by 134.86% to $903.0 million in 2025, then tumbled by 114.06% to -$127.0 million in 2026.
  • Per Business Quant, the three most recent readings for PFE's Short-Term Debt issuances are -$127.0 million (Q1 2026), $903.0 million (Q3 2025), and -$517.0 million (Q2 2025).